983 related articles for article (PubMed ID: 29311384)
1. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
Ostrand-Rosenberg S; Fenselau C
J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
[TBL] [Abstract][Full Text] [Related]
2. Plasticity of myeloid-derived suppressor cells in cancer.
Tcyganov E; Mastio J; Chen E; Gabrilovich DI
Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
[TBL] [Abstract][Full Text] [Related]
3. Myeloid derived-suppressor cells: their role in cancer and obesity.
Ostrand-Rosenberg S
Curr Opin Immunol; 2018 Apr; 51():68-75. PubMed ID: 29544121
[TBL] [Abstract][Full Text] [Related]
4. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
De Cicco P; Ercolano G; Ianaro A
Front Immunol; 2020; 11():1680. PubMed ID: 32849585
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
6. Importance of myeloid derived suppressor cells in cancer from a biomarker perspective.
Kalathil SG; Thanavala Y
Cell Immunol; 2021 Mar; 361():104280. PubMed ID: 33445053
[TBL] [Abstract][Full Text] [Related]
7. Targeting myeloid-derived suppressor cells for cancer immunotherapy.
Liu Y; Wei G; Cheng WA; Dong Z; Sun H; Lee VY; Cha SC; Smith DL; Kwak LW; Qin H
Cancer Immunol Immunother; 2018 Aug; 67(8):1181-1195. PubMed ID: 29855694
[TBL] [Abstract][Full Text] [Related]
8. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer.
Ma P; Beatty PL; McKolanis J; Brand R; Schoen RE; Finn OJ
Front Immunol; 2019; 10():1401. PubMed ID: 31275327
[TBL] [Abstract][Full Text] [Related]
9. The role of CCR5 in directing the mobilization and biological function of CD11b
Karin N; Razon H
Cancer Immunol Immunother; 2018 Dec; 67(12):1949-1953. PubMed ID: 30232521
[TBL] [Abstract][Full Text] [Related]
10. Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.
Moses K; Brandau S
Semin Immunol; 2016 Apr; 28(2):187-96. PubMed ID: 27067179
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy.
Parker KH; Horn LA; Ostrand-Rosenberg S
J Leukoc Biol; 2016 Sep; 100(3):463-70. PubMed ID: 26864266
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived suppressor cells and tumor escape from immune surveillance.
Umansky V; Blattner C; Fleming V; Hu X; Gebhardt C; Altevogt P; Utikal J
Semin Immunopathol; 2017 Apr; 39(3):295-305. PubMed ID: 27787613
[TBL] [Abstract][Full Text] [Related]
13. Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.
Xu W; Dong J; Zheng Y; Zhou J; Yuan Y; Ta HM; Miller HE; Olson M; Rajasekaran K; Ernstoff MS; Wang D; Malarkannan S; Wang L
Cancer Immunol Res; 2019 Sep; 7(9):1497-1510. PubMed ID: 31340983
[TBL] [Abstract][Full Text] [Related]
14. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
Qu P; Wang LZ; Lin PC
Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.
Zhou J; Nefedova Y; Lei A; Gabrilovich D
Semin Immunol; 2018 Feb; 35():19-28. PubMed ID: 29254756
[TBL] [Abstract][Full Text] [Related]
16. The diversity of circulating neutrophils in cancer.
Mishalian I; Granot Z; Fridlender ZG
Immunobiology; 2017 Jan; 222(1):82-88. PubMed ID: 26874580
[TBL] [Abstract][Full Text] [Related]
17. AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells.
Trillo-Tinoco J; Sierra RA; Mohamed E; Cao Y; de Mingo-Pulido Á; Gilvary DL; Anadon CM; Costich TL; Wei S; Flores ER; Ruffell B; Conejo-Garcia JR; Rodriguez PC
Cancer Res; 2019 Oct; 79(19):5034-5047. PubMed ID: 31409640
[TBL] [Abstract][Full Text] [Related]
18. The immunobiology of myeloid-derived suppressor cells in cancer.
Motallebnezhad M; Jadidi-Niaragh F; Qamsari ES; Bagheri S; Gharibi T; Yousefi M
Tumour Biol; 2016 Feb; 37(2):1387-406. PubMed ID: 26611648
[TBL] [Abstract][Full Text] [Related]
19. Plasticity and biological diversity of myeloid derived suppressor cells.
Ben-Meir K; Twaik N; Baniyash M
Curr Opin Immunol; 2018 Apr; 51():154-161. PubMed ID: 29614426
[TBL] [Abstract][Full Text] [Related]
20. Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive Functions.
Geis-Asteggiante L; Belew AT; Clements VK; Edwards NJ; Ostrand-Rosenberg S; El-Sayed NM; Fenselau C
J Proteome Res; 2018 Jan; 17(1):486-498. PubMed ID: 29139296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
